ABSTRACT
Aims
The aim of the study was to identify the barriers and facilitators to healthcare access for people with Parkinson's disease (PWP) in Spanish‐speaking Latin American countries (LAC) in Central and South America, to understand their drivers and consider the implications for health systems in LAC.
Methods
Four online semi‐structured focus groups were conducted with 25 PWP who provide education and/or support to PWP. The study was designed and implemented by a person with lived experience of PD. Data were mapped to an existing model of access to healthcare that incorporates provider and consumer abilities.
Findings
There were multiple provider barriers in terms of availability, affordability and appropriateness of care, driven by a lack of health system capacity. Doctors didn't recognise Parkinson's symptoms, which resulted in delayed diagnosis. Limited knowledge of Parkinson's and limited multidisciplinary care and medication was common across Spanish‐speaking Latin America. Inequities in access were experienced by those living in rural areas and those who could not afford private care. Barriers at the person level included stigma, depression and lack of health literacy around PD. Family and peer support were facilitators of access.
Conclusion
Significant gaps in Parkinson's care across Latin America are driven by stigma and limited service availability. This study highlights the need for culturally tailored interventions that address stigma, promote peer support and strengthen self‐management and health professional training across Spanish‐speaking Latin America. We call for more global partnerships to encourage training and mentoring in regional cities across Latin America with co‐designed approaches to ensure a culturally appropriate framework of care that supports patients and healthcare professionals with a focus on self‐management.
Patient or Public Contribution
The first author (C.J.) has Parkinson's disease (PD) and lived with the condition for 8 years in Peru. She was involved in all aspects of the study, including design, data collection, analysis and writing this article. C.J. is an international advocate in the PD community.
Keywords: access to healthcare, barriers, carers, Latin America, Parkinson's disease, peer support, self‐management, stigma
1. Introduction
Parkinson's disease (PD) is a complex neurodegenerative condition with motor symptoms, bradykinesia (slowness), trembling, rigidity and many non‐motor symptoms including apathy, depression and cognitive decline [1]. In 2021, 11.8 million people were estimated to be living with PD globally, making it the fastest‐growing neurological cause of disability [2]. Access to timely diagnosis, movement disorder specialists (MDS) and multidisciplinary care remains limited worldwide [3, 4, 5, 6]. These challenges are particularly pronounced in low‐ and middle‐income countries, including Latin American countries (LAC), where significant gaps remain in understanding access to barriers and their link to poorer outcomes [5, 7, 8, 9, 10].
Globally, PD prevalence is estimated at 315 per 100,000 and 472 per 100,000 in LAC, with the burden increasing due to rapid demographic ageing [11, 12]. In LAC, people with Parkinson's disease (PWP) experience higher rates of dependency, early mortality, psychiatric symptoms and poor mental health outcomes [10, 13, 14]. Yet, the influence of contextual and systemic barriers on these outcomes is underexplored. While stigma is a global issue among PWP—contributing to isolation, depression and reduced quality of life [6, 9, 15, 16, 17, 18, 19, 20]—little is known about its forms and impacts in Spanish‐speaking Latin America [21, 22, 23]. Generally, patients are often portrayed negatively in literature—as unmotivated, non‐adherent or lacking health literacy—while facilitators of access are rarely emphasised [3, 4, 6]. Communication from healthcare professionals (HCPs) is little documented in the region [3]. Likewise, existing studies primarily reflect provider perspectives, with limited input from PWP or peer advocates, which has been of value in the high‐income countries [24, 25]. Our study aims to give voice to the lived experience of Spanish‐speaking Latin Americans who can explain the unmet needs.
This study aims to identify barriers and facilitators to healthcare access for PWP in Spanish‐speaking LAC, using Levesque et al.'s access model [26], which defines access as the opportunity to obtain health when a need is perceived. The qualitative study uses focus groups with PWP who are peer advocates with personal experiences and knowledge of the experiences of others with Parkinson's, which will inform future research, policy and advocacy.
1.1. Context of Healthcare Systems
Spanish‐speaking LAC consist of 21 countries with diverse health systems, histories and economic structures [27, 28, 29] (Table 1). Many LAC have basic public health (a safety net system), but informal labour market workers in some countries cannot contribute to copayments or to tax‐based financing [30]. Public healthcare expenditure ranges from 5.6% and 9.8% of GDP (see Table 1) with significant reliance on private insurance, co‐payments and out‐of‐pocket expenditure (16%–43%) [28] (see Table 1) [27, 28].
Table 1.
Context of healthcare systems.
| Country | Population 2023 | Doctors per 10,000 | Out‐of‐pocket expend. As % of current expend. (2021) | Current health expenditure (% of GDP) |
|---|---|---|---|---|
| Argentina | 46,234,830 | 40.8 | 22.40% | 9.8 |
| Chile | 19,612,723 | 29.7 | 30.30% | 9 |
| Colombia | 52,194,491 | 24.5 | 13.70% | 7.2 |
| Ecuador | 18,511,400 | 30.60% | 8.4 | |
| El Salvador | 6,528,537 | 29.1 | 26.70% | 6.2 |
| Guatemala | 19,672,073 | 61.00% | 5.8 | |
| Mexico | 130,262,216 | 25.6 | 41,4% | 6.4 |
| Peru | 33,728,392 | 16.5 | 27.20% | 5.6 |
| Uruguay | 3,559,917 | 45.1 | 15.40% | 9.5 |
| Venezuela | 28,250,500 | 28.10% | 6.3 |
2. Methods
2.1. Study Design and Research Question
This qualitative study utilised four online semi‐structured focus groups to explore the research question: What are the barriers and facilitators to healthcare access for PWP in Spanish‐speaking LAC?
2.2. Research Team
This study was led by a lived experience researcher to explore community‐based participatory research (CBPR) involving Latin American peer advocates and PWP as co‐creators in identifying health needs and shaping recommendations [31]. Focus groups were conducted online with a psychologist of Cuban ethnicity, chairing all groups while based in the United States. The first author assisted with all groups while located in Australia. The other investigators were not involved in the conduct of the focus groups, but were involved in the planning of the study, reviewed the transcripts and contributed to the analysis, interpretation and writing. The research was overseen by the University of New South Wales (UNSW) authors and supported by a team of researchers, mainly of LAC ethnicity, from the project: The epidemiology of ParkINson in LatiN AmeriCa: Learning from undEr‐represented populations (PINNACLE).
2.3. Recruitment and Study Participants
The inclusion criteria were 18 years or older, cognitive capacity, lived experience with PD in LAC, and engagement in peer support (advocacy, education or support), which enabled peers to provide insight into PD beyond just personal experiences.
Convenience sampling was conducted via emailing the ‘Alianza Iberoamericana de Parkinson’ mailing list (140 contacts) with an invitation to complete an expression of interest. This is a Spanish‐speaking peer‐led network of independent individuals and professionals interested in PD in LAC. Ethics requested that cognitive eligibility be confirmed, which the first author led via scripted calls on MS Teams (see Appendix 1—Call Script).
Of 32 expressions of interest, 3 were ineligible (not PD peer advocates) or did not follow through, and 25 were enrolled into four groups based on availability. We monitored diversity and the final group was recruited via follow‐up email to address the deficit in diversity, which aimed to have approximate equality and diversity of countries, genders and regional/city dwelling (etc.). A group distribution table is in Appendix 2.
Four carers (three spouses and one friend) attended in a supportive role (technical/voice clarity/emotional, etc.) at the choice of the PWP and completed carer‐specific consent forms.
The sample size was chosen to follow recommendations in the literature based on expected thematic saturation [32]. There was very little new information in the fourth discussion group so it was decided that data saturation had been reached.
2.4. Data Collection
Four focus groups, held between November 2023 and February 2024, were conducted in Spanish, led by a psychologist researcher (A.M.R.S.) and assisted by C.J., who has PD and who lived in Peru for the first eight years of her diagnosis. She was involved in all aspects of the study, including design, data collection, analysis and article writing. They were conducted in Spanish and recorded on Microsoft Teams, lasting approximately 1.5–2 h each. Participants could take breaks at any time. Transcripts were auto‐generated, improved for accuracy and verified by participants. Translations into English were carefully reviewed by the first author against original Spanish transcripts and audio. Anonymity was maintained in transcripts, although not feasible during group discussions. The focus group guide is in Appendix 3.
2.5. Analysis
The following six‐step thematic analysis approach was utilised [33]: Step 1: Become familiar with the data; Step 2: Generate initial codes; Step 3: Search for themes—revising codes around the question; Step 4: Review themes; Step 5: Define themes; and Step 6: Write up the findings. At each step, the first author undertook the following: read the transcript and listened to the audio, revised the translation, highlighted key points, made notes, inductively coded, reorganised codes, performed word searches, developed process maps, compared the maps to the ‘access to healthcare’ model, renamed codes and themes, and assessed the findings for opposite experiences. NVivo 12 (Lumivero) was used as a tool to support the analysis of responses. To ensure trustworthiness, the author had prolonged engagements with the data using reflexive journaling, theme mapping and audit trails. The UNSW researchers, who oversaw the development of all research questions, proposals and documentation, discussed and reviewed the coding tree. Draft results were interrogated and refined by C.J. and C.S. using the Levesque access model, which formed the framework for presentation of the data [26]. The quotations were chosen because they were succinct, illustrative of the point being made, and demonstrating a range of patterns in data [34].
2.6. Ethics
Ethics approval was granted by the University of NSW Human Research Ethics Committee. Informed consent was obtained from all participants. While anonymity in group discussions was not possible, data were anonymised in transcripts and reporting.
3. Results
3.1. Sample Characteristics
The participants were from ten Spanish‐speaking LAC in Central and South America. About half were female, most were aged between 40 and 69 years, and age of diagnosis ranged from under 30 to over 60 years. Details are provided in Table 2.
Table 2.
Peer advocate characteristics.
| Domain | Characteristic | Number |
|---|---|---|
| Sex | Female | 12 |
| Male | 13 | |
| Age at diagnosis (years) | Under 30 | 4 |
| 30–39 | 5 | |
| 40–49 | 7 | |
| 50–59 | 7 | |
| 60–69 | 2 | |
| Years living with Parkinson's disease | 0–5 | 6 |
| 6–10 | 7 | |
| 11–19 | 7 | |
| 20+ | 5 | |
| Current age (years) | < 40 | 1 |
| 40–49 | 7 | |
| 50–59 | 8 | |
| 60–69 | 8 | |
| ≥ 70 | 1 | |
| Living arrangement | Alone | 3 |
| With partner | 9 | |
| With extended family | 13 | |
| Countries of residence | Perú | 6 |
| Argentina | 4 | |
| Mexico | 4 | |
| Chile | 3 | |
| Venezuela | 2 | |
| Colombia | 2 | |
| Ecuador | 1 | |
| El Salvador | 1 | |
| Guatemala | 1 | |
| Uruguay | 1 | |
| Socio‐economics of the PD community | Evenly mixed | 9 |
| Middle | 4 | |
| Middle to upper | 1 | |
| Lower to middle | 2 | |
| Lower | 9 | |
| Education | Completed study after Secondary School | 21 |
| Secondary schooling only | 4 | |
| City or regional | Capital City | 13 |
| Regional City | 9 | |
| Rural/village | 3 | |
| Involvement with PWP (number who answered ‘yes’) | I have research experience (participant or researcher) | 11 |
| Involved in international forums/Parkinson's‐related foundations | 19 | |
| I am a professional serving people with Parkinson's disease. | 3 | |
| I lead or educate a support group | 16 |
The results are summarised according to the Levesque access model [26] in Figure 1.
Figure 1.

Results mapped to Levesque et al.'s conceptual framework of access to healthcare [26].
3.2. Provider Capabilities
3.2.1. Approachability
Approachability refers to the visibility of relevant health services. Participants generally did not initially know where to go to access healthcare. A family in Argentina learned about a hospital when their cousin saw a promotion on television.
We found out that it is close to home, it gives monthly talks … that it gives the most complete [holistic] treatment…. So, about after 5 years [since diagnosis] we started to learn more and to connect with other people.
C7, Argentina
This was the only hospital identified as providing patient education.
3.2.2. Acceptability
The acceptability of the service is based on personal, social and professional values and norms, as well as culture, gender and autonomy. Stigma‐related fear affected acceptability and impeded help seeking and participation in support groups. One participant related a story of how people contacted him after he had been on television talking about PD. They asked for advice about their PD symptoms: ‘I have a little tremor, I have this, I have that, do you think it could be Parkinson's?’ (P13, Argentina). However, they did not want to see a doctor for fear of experiencing discrimination if it was PD. Participants reported that they and other PWP they knew were afraid to meet in a support group as they did not want people to know that they had PD, to avoid being stereotyped and treated with prejudice.
The communication between doctor and patient is often culturally mediated, and one family experienced shared their experience.
There is a hierarchical relationship between the doctor, the who looks down towards the patient and relatives. How do we empower ourselves then?
C9, Peru
This approach did not help the participant engage with their care.
3.2.3. Availability and Accommodation
Participants reported inadequate and unequal service availability: PD specialists, neurologists, allied health professionals with specific qualifications in PD, a lack of medicines and only short appointments could be obtained.
It took too long to get the diagnosis…. The barrier is the training of the [health] professionals in the initial symptoms of Parkinson's, like slowness, the neurologist doctor should know.
P8, Peru
While availability was generally inadequate, it was particularly poor in rural areas, and there was very limited private telehealth for those who could afford it.
Two years I was diagnosed wrongly with essential tremor by a provincial neurologist, but I noticed that it was obstructing me and that I couldn't move. I had to go to the capital, which is about 130 km from my residence…. I went to the public health service because I have limited resources … the appointment is not until February.
P19, Chile
While some participants could access services in a timely manner, others with fewer resources had less timely access.
I have more access because I have prepaid healthcare because I pay privately. I have immediate access.
P18, Columbia
The inadequate availability of a multidisciplinary and specialised PD workforce resulted in late diagnosis of PD; insufficient and inappropriate management of PD (discussed below); inadequate advanced care and medication; and substantially reduced quality of life.
One person in the study reported taking medication without a prescription as he was awaiting his formal diagnosis with the public system.
I think that there is a tremendous shortage of professionals, first because I am totally ignorant on the subject, and I am also self‐medicating without knowing what consequences it can bring me.
P25, Chile
Most participants reported a lack of Information from the doctor. Participants reported that access to medication was better in Argentina, Mexico and Chile than the other countries represented in the group.
3.2.4. Affordability
Commonly, there was a system of public healthcare services that could provide free or subsidised services or alternatively people and employers made co‐contributions for health insurance or private health or a combination (requiring out‐of‐pocket payments). Neither was perfect.
The private insurance system is getting more expensive. …[but] the system that is the public system …. it gives you very basic medicine, only the basic one, …as the years go by … there are no more sophisticated, higher quality medicines.
P9, Peru
In Venezuela, Guatemala, El Salvador and Mexico, participants accessed one medication through public healthcare, and often other medications were too costly for many.
3.2.5. Appropriateness
Study participants reported instances of health providers demonstrating poor communication skills, little knowledge of PD and working in isolation. Communication was described as dismissive, unhelpful and unsupportive. A participant was given her prognosis with blunt language, without an attempt to soften the hard news.
In 5 years, you will be in a wheelchair.
P18, Colombia
Such communication stigmatises the person and runs the risk of demoralising patients, erodes trust and discourages future engagement. Health professionals talked with family member rather than the patient.
I remember that the doctor sat … and he said looking at my daughter ‘How he is then?’. I didn't exist….
P9, Peru
One participant was repetitively misdiagnosed for over 15 years (P5, Mexico). When they were diagnosed, many participants reported that this consisted of little more than the phrase ‘you have Parkinson's’, followed by a prescription for medications. One participant said: ‘He sent me home without any referral’ (P17, Uruguay). She would have liked ‘an ABC guide to take home and read’ (P17, Uruguay). Information was something that participants agreed was lacking from their doctors. To access appropriate medication, one participant bought medication while on vacation in Mexico:
The variety of concentrations in medication have stopped arriving. I had the opportunity to travel to Mexico … to bring different concentrations of the medication….
P8, Peru
Availability is reducing, not improving, and this affects patients. The following participant struggles with daily activities.
I get ‘off’ periods every day throughout the day, making it very difficult for me to talk, exercise, or engage in any social activity.
P9, Peru
Thus, medication unavailability influences both quality of life and ability to engage in healthcare.
3.3. Consumer Abilities
3.3.1. Ability to Perceive
The ability to perceive the need for healthcare was particularly challenging pre‐diagnosis. Typically, the participants first perceived that something was wrong, but lacked the health literacy of PD to find information. The little information on PD was often inaccurate. One bilingual participant stated:
When I go in Spanish groups about Parkinson's on Facebook, the level of misinformation is frightening…. I mean, if I depended on the information I receive in Parkinson's groups, in Spanish we'd be ‘screwed’ … a magical treatment … turns out to be a scammer … people fall for these … there is a very high level of misinformation in Latin America.
C22, Ecuador
Several participants reported being in denial, and two only accepted the diagnosis after seeing 14 doctors each.
3.3.2. Ability to Seek
Low health literacy also influenced seeking care, with PWP reportedly lacking knowledge of what healthcare they needed and their healthcare entitlements.
I couldn't go further, I didn't know where to go, what kind of doctor to go to.
P12, Mexico
Without access to reliable information, PWP were at a loss for how to manage the disease.
Peer support groups have used online methods since Covid to try to educate PWP about PD and how to seek care, and another created a network in her country with other peers and carers. Participants became facilitators of peers ‘ability to seek’. See Table 2 which shows 16 led support groups.
Some participate in WhatsApp and then they share information…. We are trying to encourage people to be in groups, to be connected to each other and they help themselves.
P7, Argentina
Finding doctors and support groups and sharing their knowledge of their own healthcare entitlements was common among participants.
I got … a certificate of disability and in Argentina, this means medication is 100% free.
P7, Argentina
One participant explained it was an honour to support the community.
I have been enriched, I have been empowered by my peers…, so I also feel a commitment to contribute. I can help with my testimony.
P12, Mexico
This participant felt good about helping each other and empowered.
3.3.3. Ability to Reach
Barriers to the ability to reach care included stigma and poor health. For all PWP, particularly those who had to travel from rural to urban locations for treatment, they required time, financial resources, adequate physical mobility, mental well‐being and support. They could be hindered by fear of embarrassment and discrimination due to PD stigma, particularly when the PD symptoms were noticeable.
When one becomes embarrassed by Parkinson's, the person isolates, and the disease progresses further…. The prejudice that others have makes people want to remain in their homes; they do not want to go out….
and if they are invited to eat or something, they give an excuse. It has also happened to me because of depression. Depression also occurs because of Parkinson's, and that makes us isolate ourselves.
P7, Argentina
To address the difficulties in reaching services during the Covid pandemic, some peer groups organised online classes, ‘physical therapy, meditation, yoga, tai chi, and painting, among others’ (P5, Mexico), which also helped address isolation.
3.3.4. Ability to Pay
Some participants in the study reported that they had the ability to pay for the healthcare. However, they noted that they were not typical of PWP in their countries.
I recognize that I have enough resources or sufficient resources to access medicine … people who have fewer resources, in general, they go to the offices of the public health system and there they just give them an appointment for 6 months later.
P1, Chile
Many relied on family to assist with the costs of medicine and healthcare. Family was often mentioned as helpful in seeking healthcare like the example of a brother being helped to get a bus to Lima for treatment.
I took the courage to tell my brothers that I had this disease. So, my brother gave me a ticket to go to Lima and helped him go to clinics.
P24, Peru
This participant eventually accessed an expert in PD in Lima. He stayed in Lima for treatment and lived with members of his extended family.
3.3.5. Ability to Engage
PWP were reported to be active in asking questions of health professionals, but the health professionals tended to provide little information.
I've asked questions because I have atrophies, and I don't know what they are. He just says ‘it's part of PD. He doesn't explain what that means’.
P3, El Salvador
Family members were mentioned as helpful in the process of actively engaging in care.
I'm very happy to be with my wife because she has helped me enormously. She discovered alternative treatments that the neurologist didn't know about.
P22, Ecuador
Family and peer support groups were mentioned throughout the access journey. It is noted that family support was predominantly provided by women, for example, ‘my wife’ and ‘my daughter’. A peer was also able to help connect a participant and his carer wife to a support group.
We sat and we talked. I'm grateful as she introduced us to the support group….
So, I joined a group … and people are enthusiastic. We have, let's say, about 30, but about 12‐15 of us participate. But every day we communicate through a chat, every day. It's a living group.
C9, Peru
This carer valued being in the community. Being supported helps both carers and PWP. For some participants, the facilitator of health was to proactively improve theirhealth with exercise.
The exercise, that is soccer, has served as medicine. It has kept me well … thank God my Parkinson's has not advanced. My neurologist said that I am not advancing at all.
P20, Colombia
This young‐onset participant had improved his health. Poor health had the opposite effect. Depression was repeatedly mentioned as a barrier to accessing services.
The lady is 39 years old … I ask her ‘Do you exercise?’ … but because she is very depressed, she tells me ‘no’ I explain to her, ‘but you need to exercise to be able to motivate yourself‐ if not it's a vicious circle.’
P16, Mexico
Limited access has negative consequences.
4. Discussion
This qualitative regional study offers a crucial insight for policymakers and healthcare providers regarding resource gaps and patient needs in Latin America, carefully mapped to Levesque et al.'s conceptual framework of access (Figure 1) [26]. The study identified the barriers and facilitators of healthcare access for PWP in 10 Spanish‐speaking LAC from the perspective of PWP who are peer advocates. Access to treatment for PWP in LAC is hindered by the lack of availability, acceptability and appropriateness of PD treatment. Many of the deficits resonate with the literature globally [5, 6, 9] and the resource constraints and stigma experienced in Africa [15, 35]. Our findings reveal the role of family and peer support, alongside increasing online access, in fostering healthcare engagement and promoting overall health and wellness.
Our study confirmed limited access to healthcare services for PD, including allied HCP services [10, 12]. HCPs lacked training in PD and often failed to recognise initial PD symptoms, resulting in diagnostic delays, particularly for women, as reported in another study [36]. Geographic, financial and digital disparities restrict access, which is not dissimilar to disparity elsewhere [6, 16, 21, 37, 38, 39]. As a result of limited access, PWP frequently experienced difficulties in accessing timely, comprehensive, evidence‐based treatment such as exercise therapies for symptom management [40, 41]. This deficit in early intervention is known to contribute to increased dependency and reduced quality of life [16, 42]. PD is inherently neurodegenerative. Kim et al. [10] observed rapid disease progression in Latin America. Recent findings of significant decline in quality of life [43] suggest a rapid pace of neurodegeneration in people with PD in the region. Healthcare training needs a focus on recognition of PD symptoms, initial diagnosis and symptom management [44].
The most surprising and disheartening finding was the prevalent accounts of dismissive communication styles employed by HCPs, which consequently led to distrust rather than much‐needed empathy and hope [19]. HCP poor communication has been previously cited in the literature as a barrier [6]. The statement ‘In 5 years you will be in a wheelchair’ highlights the harsh reality and the constrained expectations of some doctors in Latin America [6, 45] and undeniably contributed to patient demoralisation. This suggests the need to build sensitivity in professional communication and provide person‐centred care [45].
One of the more pervasive barriers to seeking and receiving appropriate care, reported at both system and person levels, was stigma [17]. Stigma is a complex concept that can be divided into public stigma and anticipated or self‐stigma. Public stigma comprises negative attitudes or stereotyping from others (such as health professionals) [46]. Self‐stigma exists when a person internalises this negative stereotyping [18]. Our study revealed that stigma impeded the processes of obtaining a diagnosis, receiving treatment and engaging with support groups, which can result in profound isolation for the PWP. Some literature exists on stigma in Brazil, but there is insufficient research in the Spanish‐speaking Latin American context to understand it well [21, 22, 23]. For example, elsewhere, stigma has been found to adversely affect quality of life and physical and mental health, resulting in social isolation and reluctance to seek healthcare [17]. In high‐income countries, stigma contributes to a lack of acceptance, isolation and loneliness, worsened symptom severity, and reduced quality of life for PWP [19, 22, 47, 48]. If stigma has similar impacts in Latin America, not addressing it will diminish health‐seeking and worsen both mental and physical health [15, 26, 49]. This affects quality of life and even survival in PWP in high‐ and low‐income countries [15, 50]. Stigma interventions are needed according to the World Health Organization [9, 39]. Strategies to create public awareness are needed [15, 17, 47]. The video‐based PD education campaign in Thailand, with 4.4 million YouTube views, is a good example of this [51]. The campaign received comments showing people became empathic and had a new understanding of PD [50, 51]. Ultimately, stigma is frequently rooted in misinformation about causes and must be addressed. Further research is needed to understand stigma and create inventions to address it.
This study illuminates the vital role family members, peers and support groups play in facilitating access to, and engagement with, health services for PWP. This finding is relatively undocumented in Latin America but resonates with research from Africa, where peer support groups provided a source of education, social support and legitimacy that participants perceived as largely absent from formal healthcare systems [35]. While most study participants were highly engaged, they reported that most PWP, whom they knew, were less engaged. One participant shared her testimony ‘to encourage others’ because she felt ‘empowered by her peers’, reflecting how such support fostered psychological strength and social cohesion [52]. Similarly, a UK‐based study highlighted that peer narratives supported individuals in adapting to lifestyle changes, including engagement with exercise [53]. Family members helped PWP to access care and provided emotional support, aligning with findings by Zhu et al. [54]. Our findings suggest carers enjoy support and confirm the need for self‐care for carers [55, 56]. Across diverse LAC, ‘social support’ has been consistently reported as the most important factor for ‘living well’ with PD [57]. Our study confirmed the importance of social support and promoting and supporting peer groups [19, 58].
The Covid‐19 pandemic unexpectedly accelerated the adoption of online platforms, enabling PWP to access educational and peer support forums from home [4, 35, 59]. In this study, 19 of the 25 participants engaged with such online forums (see Table 2), which facilitated disease‐specific knowledge acquisitions, opportunities to ask questions, reduced stigma and barriers to exercise. Previous research similarly confirms that online group participation can reduce isolation and improve quality of life among PWP in Africa [60]. Despite improved access, beyond webinars, the study found that online content poses challenges for PWP with low health literacy, who may struggle to identify trustworthy sources [4]. This underscores the need for credible self‐management resources from a trusted source and basic health literacy training to support informed online engagement [4]. Online solutions could be further utilised for training health professionals or for online appointments, telehealth, albeit with a need for HCP upskilling in online PD management [61].
Self‐management interventions, widely adopted in high‐income countries, support PWP and carers in building the knowledge and skills necessary to manage symptoms, medication and psychosocial well‐being [62, 63]. These approaches typically include structured resource kits (in print, digital or app‐based formats) and promote patient activation through education, emotional support, exercise and peer engagement [64]. Self‐management can reduce hospitalisations and improve outcomes in chronic disease populations [47, 64, 65]. Self‐management interventions remain largely absent across LAC. Health systems and NGOs should invest in the development of a self‐management programme based on a core resource kit that can be adapted. Co‐designed strategies could ensure culturally relevant materials and Latin American examples of success, like the Saturday in Motion project in Colombia [66]. Another example of a project is A Movement Disorder Society‐sponsored partnership between the University of Rochester and the hospital in regional Peru (Arequipa), which has demonstrated the feasibility of international partnerships to build capacity and of HCP and PWP and could be adapted to teach PD self‐management skills and improve patient outcomes [67]. Replicating such models in other underserved regions of Latin America could accelerate the dissemination of evidence‐based care and expand access to person‐centred support, which has been done many times before [2, 68, 69, 70, 71]. It is prudent to carefully consider the research to evaluate how these partnerships influence care delivery and whether tailored self‐management interventions can improve health equity in LAC contexts.
5. Limitations
Due to the requirements for written consent, a stable internet connection, computer literacy, and work as a peer advocate or educator, study participants tended to be more educated and financially resourced than the population of PWP in LAC. Participants were younger than most PWP, as PD is most frequent in people over 60 years of age; however, only 9 of the 25 participants were in that age group. While the group was not typical of PWP in their country, they brought the experience and stories of PWP with whom they worked and who they taught, thus providing a wider diversity of experiences than their own. Some participants were very eloquent, and their words featured more in the findings than others. However, their views were generally reflective of the views of the group. These findings are not necessarily representative of all experiences across the countries included, but point to common patterns of service under‐provision and lack of PD awareness and education amongst HCPs across the countries.
6. Recommendations
All recommendations should be enacted in Partnership with Parkinson's experts, HCP and PWP and carers:
-
1.
Stigma and anti‐stigma interventions:
Research is needed to further understand stigma and barriers to healthcare to create interventions tailored to each country in Latin America. It is recommended that interventions adopt a multilevel educational approach with patients, family, community, support groups, health professionals and media campaigns for the public.
-
2.
Creation or adaption of a self‐management toolkit to address the deficit of information from reliable sources and to provide HCP and patients and family a tool where they can be one the same page. Training is needed for HCPs and peer leaders, PWP and family in self‐management.
-
3.
Training of HCPs in person‐centred care and focused on symptoms of Parkinson's, diagnosis and self‐management as per the self‐management toolkit.
-
4.
Global collaboration and partnerships between universities and hospitals could improve PD management capacity and pilot a self‐management approach in regional cities of LAC which would be highly advantageous.
7. Conclusion
This study makes a significant contribution to the field by shifting the lens from provider‐centric views to the lived realities of PWP in Latin America—voices that have been largely absent in the research to date. It identifies systemic limitations in diagnostic capacity and care quality, exacerbated by insufficient HCP training and stigma, a deeply embedded, culturally shaped barrier to care that needs further research to identify interventions that can remove stigma. Peers, family and support groups are facilitating access to healthcare, but a self‐management framework would be useful to strengthen the roles of family and peers further. Funding bodies, policymakers, HCPs and peer advocates each have a critical role to play in collaborative efforts to fund, prioritise and co‐design and implement a self‐management toolkit. Working together is the best way to address the barriers and celebrate the strengths and self‐management potential of the PD community in Latin America.
Author Contributions
Christine Jeyachandran: lead author, study design, data collection, analysis, interpretation, writing, editing. Catherine Spooner: academic supervisor, study design, data analysis, writing. Ana Margarita Rodriguez Salgado: focus group lead, data collection, analysis, interpretation, reviewing. Matthew Prina: chief investigator of PINNACLE Team, Michael J. Fox Grant, study design, writing, editing. Joel Rhee: academic supervisor, analysis, interpretation, writing. Jorge Jesus Llibre‐Guerra: grant application, study design, editing. Dani Kim: study design, editing. Juan J. Llibre‐Rodriguez: study design. Mark F. Harris: primary academic supervisor, study design, analysis and interpretation, writing.
Disclosure
The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Ethics Statement
The project was approved by the University of New South Wales (UNSW) Human Research Executive Committee on 8 June 2023 (identification number HC230231).
Consent
All participants provided written informed consent.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Appendix_1_Call_Script.
Appendix_2_Focus_Group_Composition.
Appendix_3_Focus_Group_Guide.
Acknowledgements
We extend our deepest gratitude to all people with Parkinson's disease and their families affected by Parkinson's disease who shared their experiences through the focus group discussions, enriching our study. This study was supported by the Michael J. Fox Foundation for Parkinson's Research (Grant No. MJFF‐020770). Open access publishing facilitated by University of New South Wales, as part of the Wiley ‐ University of New South Wales agreement via the Council of Australian University Librarians.
Data Availability Statement
Code lists are available upon request from the corresponding author. Our Ethics Committee approval does not allow the provision of research data to external researchers.
References
- 1. Bloem B. R., Okun M. S., and Klein C., “Parkinson's Disease,” Lancet 397, no. 10291 (2021): 2284–2303, 10.1016/S0140-6736(21)00218-X. [DOI] [PubMed] [Google Scholar]
- 2. Steinmetz J. D., Seeher K. M., Schiess N., et al., “Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021,” Lancet Neurology 23, no. 4 (2024): 344–381, 10.1016/S1474-4422(24)00038-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Castro G. S., Aguilar‐Alvarado C. M., Zúñiga‐Ramírez C., et al., “Adherence to Treatment in Parkinson's Disease: A Multicenter Exploratory Study With Patients From Six Latin American Countries,” Parkinsonism & Related Disorders 93 (2021): 1–7. [DOI] [PubMed] [Google Scholar]
- 4. Esper C. D., Valdovinos B. Y., and Schneider R. B., “The Importance of Digital Health Literacy in an Evolving Parkinson's Disease Care System,” Supplement, Journal of Parkinson's Disease 14, no. Suppl 1 (2024): 181, 10.3233/JPD-230229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Schiess N., Cataldi R., Okun M. S., et al., “Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority,” JAMA Neurology 79, no. 9 (2022): 929–936, 10.1001/jamaneurol.2022.1783. [DOI] [PubMed] [Google Scholar]
- 6. Zaman M. S., Ghahari S., and McColl M. A., “Barriers to Accessing Healthcare Services for People With Parkinson's Disease: A Scoping Review,” Journal of Parkinson's Disease 11, no. 4 (2021): 1537–1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Caramelli P., Conforto A. B., Verdugo R. J., and Allegri R., “eNeurologicalSci–Special Issue on Neurological Disorders in South America,” eNeurologicalSci 5 (2016): 41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Márquez‐Cruz M., Díaz‐Martínez J. P., Soto‐Molina H., et al., “A Systematic Review and Mixed Treatment Comparison of Monotherapy in Early Parkinson's Disease: Implications for Latin America,” Expert Review of Pharmacoeconomics & Outcomes Research 16, no. 1 (2016): 97–102, 10.1586/14737167.2016.1135740. [DOI] [PubMed] [Google Scholar]
- 9. World Health Organization , Parkinson Disease: A Public Health Approach. Technical Brief (World Health Organization, 2022), accessed November 25, 2024, https://iris.who.int/handle/10665/355973. [Google Scholar]
- 10. Kim D. J., Rodriguez‐Salgado A. M., Llibre‐Rodriguez J. J., et al., “Burden of Parkinsonism and Parkinson's Disease on Health Service Use and Outcomes in Latin America,” Journal of Parkinson's Disease 13, no. 7 (2023): 1199–1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kim D. J., Isidro‐Pérez A. L., Doering M., et al., “Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta‐Analysis,” Movement Disorders 39, no. 1 (2024): 105–118, 10.1002/mds.29682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Llibre‐Guerra J. J., Prina M., Sosa A. L., et al., “Prevalence of Parkinsonism and Parkinson Disease in Urban and Rural Populations From Latin America: A Community Based Study,” Lancet Regional Health 7 (2022): 100136, 10.1016/j.lana.2021.100136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Custodio N., Alva‐Diaz C., Morán‐Mariños C., et al., “Factors Associated With Depression in Patients With Parkinson's Disease A Multicenter Study in Lima, Peru,” Dementia & Neuropsychologia 12 (2018): 292–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rodriguez Salgado A. M., Acosta I., Kim D. J., et al., “Prevalence and Impact of Neuropsychiatric Symptoms in Normal Aging and Neurodegenerative Syndromes: A Population‐Based Study From Latin America,” Alzheimer's & Dementia 19, no. 12 (2023): 5730–5741, 10.1002/alz.13384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Fothergill‐Misbah N., “The Lived Experience of Stigma and Parkinson's Disease in Kenya: A Public Health Challenge,” BMC Public Health 23, no. 1 (2023): 364, 10.1186/s12889-023-15278-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Gavidia M., “Access to Parkinson Disease Medication Affected in Low‐Income Countries,” AJMC (September 23, 2020), https://www.ajmc.com/view/access-to-parkinson-disease-medication-affected-in-low-income-countries. [Google Scholar]
- 17. McDaniels B., Pontone G. M., Mathur S., and Subramanian I., “Staying Hidden: The Burden of Stigma in PD,” Parkinsonism & Related Disorders 116 (2023): 105838, 10.1016/j.parkreldis.2023.105838. [DOI] [PubMed] [Google Scholar]
- 18. Quinn D. M., Williams M. K., and Weisz B. M., “From Discrimination to Internalized Mental Illness Stigma: The Mediating Roles of Anticipated Discrimination and Anticipated Stigma,” Psychiatric Rehabilitation Journal 38, no. 2 (2015): 103–108, 10.1037/prj0000136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Subramanian I., Farahnik J., and Mischley L. K., “Synergy of Pandemics‐Social Isolation Is Associated With Worsened Parkinson Severity and Quality of Life,” npj Parkinson's Disease 6, no. 1 (2020): 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Tsiang J. T. and Woo B. K., “The Stigma of Parkinson's Disease: Development and Implications,” in Diagnosis and Management in Parkinson's Disease (Elsevier, 2020), 283–294, accessed November 25, 2024, https://www.sciencedirect.com/science/article/pii/B978012815946000017X. [Google Scholar]
- 21. Ferraz D. D., Carmo A. P., Sales M., Trippo K. V., and Filho J. O., “Factors Correlated With Social Participation of Latin American Older Adults With Mild/Moderate Parkinson's Disease,” Physical & Occupational Therapy in Geriatrics (2025): 1–13, 10.1080/02703181.2025.2487081. [DOI] [Google Scholar]
- 22. Rosa T. and Scorza F. A., “Stigma in Parkinson's Disease: Placing It Outside the Body,” Clinics 77 (2022): 100008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Smith E. R., Perrin P. B., Tyler C. M., Lageman S. K., and Villaseñor T., “Cross‐Cultural Differences in Parkinson's Disease Caregiving and Burden Between the United States and Mexico,” Brain and Behavior 10, no. 9 (2020): e01753, 10.1002/brb3.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Forsythe L. P., Ellis L. E., Edmundson L., et al., “Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned,” Journal of General Internal Medicine 31, no. 1 (2016): 13–21, 10.1007/s11606-015-3450-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Riggare S., Stecher B., and Stamford J., “Patient Advocates Respond to ‘Utilizing Patient Advocates…’ by Feeney et al,” Health Expectations 23, no. 4 (2020): 972–973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Levesque J. F., Harris M. F., and Russell G., “Patient‐Centred Access to Health Care: Conceptualising Access at the Interface of Health Systems and Populations,” International Journal for Equity in Health 12, no. 1 (2013): 18, 10.1186/1475-9276-12-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Cotlear D., Gómez‐Dantés O., Knaul F., et al., “Overcoming Social Segregation in Health Care in Latin America,” Lancet 385, no. 9974 (2015): 1248–1259, 10.1016/S0140-6736(14)61647-0. [DOI] [PubMed] [Google Scholar]
- 28. Kanavos P., Parkin G. C., Kamphuis B., and Gill J., “Latin America Healthcare System Overview,” London School of Economics and Political Science (2019), https://www.lse.ac.uk/business/consulting/reports/latin-america-healthcare-system-overview. [Google Scholar]
- 29. OECD . 2020. Health at a Glance: Latin America and the Caribbean 2020 | OECD iLibrary, accessed December 1, 2024, https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-latin-america-and-the-caribbean-2020_6089164f-en.
- 30. Bancalari A., Berlinski S., Buitrago G., García M. F., de la Mata D., and Vera‐Hernández M., “Health Systems and Health Inequalities in Latin America†,” supplement, Oxford Open Economics 4, no. Suppl_1 (2025): i122–i147, 10.1093/ooec/odae029. [DOI] [Google Scholar]
- 31. Tang Yan C., Johnson K., Kwesele C., Araujo Brinkerhoff C., and Sprague Martinez L., “Critical Reflections From Doctoral Students Engaging in Local and Transnational Community‐Based Participatory Research (CBPR) Approaches to Health Promotion,” Journal of Social Work Education 58, no. 2 (2022): 245–258, 10.1080/10437797.2021.1883491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Hennink M. and Kaiser B. N., “Sample Sizes for Saturation in Qualitative Research: A Systematic Review of Empirical Tests,” Social Science & Medicine 292 (2022): 114523, 10.1016/j.socscimed.2021.114523. [DOI] [PubMed] [Google Scholar]
- 33. Braun V. and Clarke V.. 2021. Thematic Analysis: A Practical Guide, accessed November 25, 2024, https://www.torrossa.com/it/resources/an/5282292.
- 34. Lingard L., “Beyond the Default Colon: Effective Use of Quotes in Qualitative Research,” Perspectives on Medical Education 8, no. 6 (2019): 360–364, 10.1007/s40037-019-00550-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Fothergill‐Misbah N., Moffatt S., Mwithiga H., Hampshire K., and Walker R., “The Role of Support Groups in the Management of Parkinson's Disease in Kenya: Sociality, Information and Legitimacy,” Global Public Health 17, no. 8 (2021): 1773–1783, 10.1080/17441692.2021.1954227. [DOI] [PubMed] [Google Scholar]
- 36. Ramchandra J., et al., 2023. Country and Sex Differences in Diagnosis Latency of Parkinson's Disease in Latin American Populations. In: MDS Abstracts, accessed April 30, 2025, https://www.mdsabstracts.org/abstract/country-and-sex-differences-in-diagnosis-latency-of-parkinsons-disease-in-latin-american-populations/.
- 37. Aamodt W. W., Kluger B. M., Mirham M., et al., “Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature From 2017‐2022,” Journal of Geriatric Psychiatry and Neurology 37, no. 2 (2024): 96–113, 10.1177/08919887231195219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. O'Shea E., Rukundo A., Foley G., Wilkinson T., and Timmons S., “Experiences of Health Service Access: A Qualitative Interview Study of People Living With Parkinson's Disease in Ireland,” Health Expectations 27, no. 1 (2024): e13901, 10.1111/hex.13901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. World Health Organization . Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022‐2031, https://iris.who.int/handle/10665/371495. [DOI] [PubMed]
- 40. Dommershuijsen L. J., Darweesh S. K. L., Ben‐Shlomo Y., Kluger B. M., and Bloem B. R., “The Elephant in the Room: Critical Reflections on Mortality Rates Among Individuals With Parkinson's Disease,” npj Parkinson's Disease 9, no. 1 (2023): 145, 10.1038/s41531-023-00588-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Langeskov‐Christensen M., Franzén E., Grøndahl Hvid L., and Dalgas U., “Exercise as Medicine in Parkinson's Disease,” Journal of Neurology, Neurosurgery & Psychiatry 95, no. 11 (2024): 1077–1088, 10.1136/jnnp-2023-332974. [DOI] [PubMed] [Google Scholar]
- 42. Fothergill‐Misbah N., Hooker J., Kwasa J., and Walker R., “Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration,” Movement Disorders Clinical Practice 11, no. 11 (2024): 1373–1378, 10.1002/mdc3.14192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Acurio K., gavino A. P., Paredes N. C., et al., “Quality of Life in Patients With Parkinson's Disease in Latin America: A Systematic Review (P4‐5.011),” supplement, Neurology 104, no. 7_Suppl_1 (2025): 6020, 10.1212/WNL.0000000000212732. [DOI] [Google Scholar]
- 44. Bhidayasiri R., Kalia L. V., and Bloem B. R., “Tackling Parkinson's Disease as a Global Challenge,” Journal of Parkinson's Disease 13, no. 8 (2023): 1277–1280, 10.3233/JPD-239005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Subramanian I., Pushparatnam K., McDaniels B., Mathur S., Post B., and Schrag A., “Delivering the Diagnosis of Parkinson's Disease—Setting the Stage With Hope and Compassion,” Parkinsonism & Related Disorders 118 (2024): 105926, 10.1016/j.parkreldis.2023.105926. [DOI] [PubMed] [Google Scholar]
- 46. Corrigan P. W. and Rao D., “On the Self‐Stigma of Mental Illness: Stages, Disclosure, and Strategies for Change,” Canadian Journal of Psychiatry 57, no. 8 (2012): 464–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Ahn S., Springer K., and Gibson J. S., “Social Withdrawal in Parkinson's Disease: A Scoping Review,” Geriatric Nursing 48 (2022): 258–268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. González D. A., Tosin M. H. S., and Goetz C. G., “The Plight of Loneliness in Parkinson's Disease: New Opportunities,” Parkinsonism & Related Disorders 105 (2022): 145–148. [DOI] [PubMed] [Google Scholar]
- 49. Stangl A. L., Earnshaw V. A., Logie C. H., et al., “The Health Stigma and Discrimination Framework: A Global, Crosscutting Framework to Inform Research, Intervention Development, and Policy on Health‐Related Stigmas,” BMC Medicine 17, no. 1 (2019): 31, 10.1186/s12916-019-1271-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Crooks S., Carter G., Wilson C. B., et al., “Exploring Public Perceptions and Awareness of Parkinson's Disease: A Scoping Review,” PLoS One 18, no. 9 (2023): e0291357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Jagota P., Jongsuntisuk P., Plengsri R., et al., “If Your Patients Were Too Embarrassed to Go Out in Public, What Would You Do?—Public Education to Break the Stigma on Parkinson's Disease Using Integrated Media,” Patient Related Outcome Measures 11 (2020): 143–148, 10.2147/PROM.S243990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Moya‐Galé G., Ahson S., Gyawali S., Lee C., O'Riordan C., and Rossi L., “Stronger Together: A Qualitative Exploration of Social Connectedness in Parkinson's Disease in the Digital Era,” American Journal of Speech‐Language Pathology 34, no. 1 (2025): 281–296, 10.1044/2024_AJSLP-24-00246. [DOI] [PubMed] [Google Scholar]
- 53. Soundy A., Collett J., Lawrie S., et al., “A Qualitative Study on the Impact of First Steps—A Peer‐Led Educational Intervention for People Newly Diagnosed With Parkinson's Disease,” Behavioral Sciences 9, no. 10 (2019): 107, 10.3390/bs9100107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Zhu A., Xie H., Wei J., Wang M., Huang T., and Mao H., “Relationship Between Stigma and Negative Emotions Among Patients With Parkinson's Disease: The Mediating Role of Health Literacy and Family Function,” Geriatric Nursing 63 (2025): 567–573, 10.1016/j.gerinurse.2025.04.004. [DOI] [PubMed] [Google Scholar]
- 55. Gerritzen A. R., Lee A. R., McDermott O., Coulson N., and Orrell M.. 2022. Online Peer Support for People With Parkinson Disease: Narrative Synthesis Systematic Review, accessed April 30, 2025, https://aging.jmir.org/2022/3/e35425. [DOI] [PMC free article] [PubMed]
- 56. Guato‐Torres P., Mendoza‐Parra S., Guato‐Torres P., and Mendoza‐Parra S., “Self‐Care of the Informal Caregiver of the Elderly in Some Latin American Countries: Descriptive Review,” Enferm Cuid Humaniz 11, no. 2 (2022), 10.22235/ech.v11i2.2917. [DOI] [Google Scholar]
- 57. Ambrosio L., Portillo M. C., Rodriguez‐Blazquez C., Rojo J. M., and Martinez‐Martin P., “Influencing Factors When Living With Parkinson's Disease: A Cross‐Sectional Study,” Journal of Clinical Nursing 28, no. 17–18 (2019): 3168–3176, 10.1111/jocn.14868. [DOI] [PubMed] [Google Scholar]
- 58. Bickerdike L., Booth A., Wilson P. M., Farley K., and Wright K.. Social Prescribing: Less Rhetoric and More Reality. A Systematic Review of the Evidence (April 2017). 10.1136/bmjopen-2016-013384. [DOI] [PMC free article] [PubMed]
- 59. Ketigian L., Piniella N., McGivney K., et al., “Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the Covid‐19 Pandemic,” Frontiers in Public Health 9 (2022): 772805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Fothergill‐Misbah N., Moffatt S., Mwithiga H., Hampshire K., and Walker R., “The Role of Support Groups in the Management of Parkinson's Disease in Kenya: Sociality, Information and Legitimacy,” Global Public Health 17, no. 8 (2022): 1773–1783, 10.1080/17441692.2021.1954227. [DOI] [PubMed] [Google Scholar]
- 61. Cubo E., Doumbe J., López E., et al., “Telemedicine Enables Broader Access to Movement Disorders Curricula for Medical Students,” Tremor and Other Hyperkinetic Movements 7 (2017): 501, 10.7916/D8708CXW. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Fabbri M., Caldas A. C., Ramos J. B., et al., “Moving Towards Home‐Based Community‐Centred Integrated Care in Parkinson's Disease,” Parkinsonism & Related Disorders 78 (2020): 21–26, 10.1016/j.parkreldis.2020.07.001. [DOI] [PubMed] [Google Scholar]
- 63. Kessler D., Hauteclocque J., Grimes D., Mestre T., Côtéd D., and Liddy C., “Development of the Integrated Parkinson's Care Network (IPCN): Using Co‐Design to Plan Collaborative Care for People With Parkinson's Disease,” Quality of Life Research 28, no. 5 (2019): 1355–1364, 10.1007/s11136-018-2092-0. [DOI] [PubMed] [Google Scholar]
- 64. Davies N., Armstrong M., Pigott J. S., et al., “Co‐Design of a Facilitated Self‐Management Toolkit for People With Parkinson's Disease,” Health Expectations 27, no. 6 (2024): e70104, 10.1111/hex.70104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Basu R., Ory M. G., Towne S. D., Smith M. L., Hochhalter A. K., and Ahn S., “Cost‐Effectiveness of the Chronic Disease Self‐Management Program: Implications for Community‐Based Organizations,” Frontiers in Public Health 3 (2015), 10.3389/fpubh.2015.00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Muñoz B. E., Quintana‐Peña V., Gonzalez M. C., et al., “Saturdays‐in‐Motion: Education and Empowerment Through an Interdisciplinary Team Approach for Parkinson's Disease in Cali‐Colombia,” Parkinson's Disease 2020 (2020): 2497386, 10.1155/2020/2497386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Lizarraga K. and Carmarrgo I.. The MDS Center to Center Program Between Hospital Honorio Delgado Espinoza (Arequipa, Peru) and the University of Rochester (Rochester, USA). MDS Website, accessed June 2, 2025, https://www.movementdisorders.org/Moving-Along/Center-to-Center-USA-Peru.
- 68. Basu L., Pronovost P., Molello N. E., Syed S. B., and Wu A. W., “The Role of South‐North Partnerships in Promoting Shared Learning and Knowledge Transfer,” Globalization and Health 13, no. 1 (2017): 64, 10.1186/s12992-017-0289-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Greive‐Price T., Mistry H., and Baird R., “North–South Surgical Training Partnerships: A Systematic Review,” Canadian Journal of Surgery 63, no. 6 (2020): E551–E561, 10.1503/cjs.008219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Hanada S., “Higher Education Partnerships Between the Global North and Global South: Mutuality, Rather Than Aid,” Journal of Comparative & International Higher Education 13, no. 5 (2021): 135–144. [Google Scholar]
- 71. Ihekweazu C., Ncube F., Schoub B., et al., “A North/South Collaboration Between Two National Public Health Institutes—A Model for Global Health Protection,” Journal of Public Health Policy 36, no. 2 (2015): 181–193, 10.1057/jphp.2014.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Appendix_1_Call_Script.
Appendix_2_Focus_Group_Composition.
Appendix_3_Focus_Group_Guide.
Data Availability Statement
Code lists are available upon request from the corresponding author. Our Ethics Committee approval does not allow the provision of research data to external researchers.
